Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndromeActive, not recruitingPhase 32026-08-12NCT06517758

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Augusta University GeorgiaAugustaUnited States8
California Pacific Medical CenterSacramentoUnited States2
Duke University Medical CenterDurhamUnited States505
Fullerton Neuro and Headache CtrFullertonUnited States5
Henry Ford Health SystemDetroitUnited States147
Honor Health Research InstituteScottsdaleUnited States17
Massachusetts General HospitalBostonUnited States1015
Mid Atlantic Epilepsy and Sleep CtrBethesdaUnited States4
Nerve and Muscle Center of TexasHoustonUnited States8
Penn Presbyterian Medical CenterPhiladelphiaUnited States44
Prairie Heart InstituteSpringfieldUnited States2
University of Chicago Medical CentrChicagoUnited States2
Vanderbilt University Medical CenterXNashvilleUnited States2